2,223 results on '"Moss, Bernard"'
Search Results
2. Understanding the biology of monkeypox virus to prevent future outbreaks
3. Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice
4. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection
5. The Origins of the French Labor Movement : The Socialism of Skilled Workers 1830–1914
6. One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection
7. Decline of Mpox Antibody Responses After Modified Vaccinia Ankara–Bavarian Nordic Vaccination.
8. Repair of a previously uncharacterized second hostrange gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells
9. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques
10. Vaccinia Virus Ankyrin-Repeat/F-Box Protein Targets Interferon-Induced IFITs for Proteasomal Degradation
11. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques
12. First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
13. Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates
14. Spirituality, social work education and workplace well-being : towards a critical framework
15. Poxvirus Multiprotein Entry-Fusion Complex
16. External Scaffold of Spherical Immature Poxvirus Particles Is Made of Protein Trimers, Forming a Honeycomb Lattice
17. Interferon Function Is Not Required for Recovery from a Secondary Poxvirus Infection
18. Ephrin-B2 Ligand Is a Functional Receptor for Hendra Virus and Nipah Virus
19. Development of a Transgenic Mouse Model Susceptible to Human Coronavirus 229E
20. The 1.51-Å Structure of the Poxvirus L1 Protein, a Target of Potent Neutralizing Antibodies
21. Discovery of Antivirals against Smallpox
22. Severe Acute Respiratory Syndrome Coronavirus Spike Protein Expressed by Attenuated Vaccinia Virus Protectively Immunizes Mice
23. Highly Attenuated Smallpox Vaccine Protects Mice with and without Immune Deficiencies against Pathogenic Vaccinia Virus Challenge
24. Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutants
25. Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost
26. Triad of human cellular proteins, IRF2, FAM111A, and RFC3, restrict replication of orthopoxvirus SPI-1 host-range mutants
27. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge
28. Poxvirus DNA Topoisomerase Knockout Mutant Exhibits Decreased Infectivity Associated with Reduced Early Transcription
29. Shared Modes of Protection against Poxvirus Infection by Attenuated and Conventional Smallpox Vaccine Viruses
30. Cloning the Vaccinia Virus Genome as a Bacterial Artificial Chromosome in Escherichia coli and Recovery of Infectious Virus in Mammalian Cells
31. Complete Pathway for Protein Disulfide Bond Formation Encoded by Poxviruses
32. Oligomeric Structure of Virion-Associated and Soluble Forms of the Simian Immunodeficiency Virus Envelope Protein in the Prefusion Activated Conformation
33. Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
34. Resilience and Spirituality
35. The Role of Pastoral Care
36. A Viral Member of the ERV1/ALR Protein Family Participates in a Cytoplasmic Pathway of Disulfide Bond Formation
37. Bacterial-Type DNA Holliday Junction Resolvases in Eukaryotic Viruses
38. Genome-Wide Analysis of Vaccinia Virus Protein-Protein Interactions
39. Mucosal Vaccination Overcomes the Barrier to Recombinant Vaccinia Immunization Caused by Preexisting Poxvirus Immunity
40. Investigating Viruses during the Transformation of Molecular Biology
41. A homolog of the variola virus B22 membrane protein contributes to ectromelia virus pathogenicity in the mouse footpad model
42. Identification of a Transcription Factor, Encoded by Two Vaccinia Virus Early Genes, That Regulates the Intermediate Stage of Viral Gene Expression
43. Vaccination with a Recombinant Vaccinia Virus Encoding a "self" Antigen Induces Autoimmune Vitiligo and Tumor Cell Destruction in Mice: Requirement for Cd4 + T Lymphocytes
44. Recombinant Modified Vaccinia Virus Ankara-Simian Immunodeficiency Virus gag pol Elicits Cytotoxic T Lymphocytes in Rhesus Monkeys Detected by a Major Histocompatibility Complex Class I/Peptide Tetramer
45. Broad Spectrum Chemokine Antagonistic Activity of a Human Poxvirus Chemokine Homolog
46. Mucosal Immunization with HIV-1 Peptide Vaccine Induces Mucosal and Systemic Cytotoxic T Lymphocytes and Protective Immunity in Mice against Intrarectal Recombinant HIV-Vaccinia Challenge
47. Ultraviolet-Induced Cell Death Blocked by a Selenoprotein from a Human Dermatotropic Poxvirus
48. Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1
49. Antigen Expression by Dendritic Cells Correlates with the Therapeutic Effectiveness of a Model Recombinant Poxvirus Tumor Vaccine
50. Death Effector Domain-Containing Herpesvirus and Poxvirus Proteins Inhibit Both Fas- and TNFR1-Induced Apoptosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.